Patient Leaflet Updated 29-Jan-2024 | Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Carbamazepine 100 mg/5 ml Oral Suspension
Carbamazepine SUN 100 mg/5 ml Oral Suspension
carbamazepine
1. What Carbamazepine SUN is and what it is used for
2. What you need to know before you take Carbamazepine SUN
3. How to take Carbamazepine SUN
4. Possible side effects
5. How to store Carbamazepine SUN
6. Contents of the pack and other information
Carbamazepine SUN is a pale orange suspension. Carbamazepine, the active ingredient in the suspension, can affect the body in several different ways.
Carbamazepine SUN is an anti-convulsant medicine (prevents fits), it can also modify some types of pain and can control mood disorders.
Carbamazepine SUN is used
A small number of people being treated with anti-epileptics such as carbamazepine have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.
Serious skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of carbamazepine. Frequently, the rash can involve ulcers of the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These serious skin rashes are often preceded by influenza-like symptoms fever, headache, body ache (flu-like symptoms). The rash may progress to widespread blistering and peeling of the skin. The highest risk for occurrence of serious skin reactions is within the first months of treatment.
These serious skin reactions can be more common in people from some Asian countries. The risk of these reactions in patients of Han Chinese or Thai origin may be predicted by testing a blood sample of these patients. Your doctor should be able to advise if a blood test is necessary before taking carbamazepine.
If you develop a rash or these skin symptoms, stop taking carbamazepine and contact your doctor immediately.
If you experience dizziness, drowsiness, decrease in blood pressure, confusion due to carbamazepine treatment, this may lead to falls.
You should also ask yourself these questions before taking carbamazepine. If the answer to any of these questions is YES, discuss your treatment with your doctor or pharmacist because carbamazepine might not be the right medicine for you.
Because of the way that Carbamazepine SUN works, it can affect, and be affected by, lots of other things that you might be eating or medicines that you are taking. It is very important to make sure that your doctor knows all about what else you are taking, including anything that you have bought from a chemist or health food shop. It may be necessary to change the dose of some medicines, or stop taking something altogether.
There is a risk of harm to the unborn child if Carbamazepine SUN is used during pregnancy. Women of childbearing age should use effective contraception during treatment with Carbamazepine SUN and for at least two weeks after the last dose (see the information in Section 2 on pregnancy and breast-feeding).
It is important to tell your doctor or pharmacist if you are taking any other medicines for epilepsy at the same time as carbamazepine and you are pregnant, think you may be pregnant, or are planning to have a baby (see also the information in Section 2 on pregnancy and breast-feeding).
Tell the doctor if you are taking:
Pregnancy
If you are a woman who is able to have a baby and are not planning a pregnancy, you should use effective contraception during treatment with carbamazepine. Carbamazepine may affect how hormonal contraceptives, such as the contraceptive (birth control) pill, work and make them less effective at preventing pregnancy. Talk to your doctor, who will discuss with you the most suitable type of contraception to use while you are taking carbamazepine. If treatment with carbamazepine is discontinued you should continue using effective contraception for at least two more weeks following discontinuation.
If you are pregnant, or think you may be pregnant, you must tell your doctor straight away and discuss possible risks the epilepsy medicine you are taking might pose to your unborn baby.
If you are planning to become pregnant you should discuss your epilepsy treatment with your doctor as early as possible before you become pregnant.
You should not stop your treatment without discussing this with your doctor. Suddenly stopping may lead to breakthrough seizures which may harm you and your unborn baby. It is important that your epilepsy remains well controlled.
Taking carbamazepine during pregnancy increases the chance that the baby may have a physical birth abnormality (major congenital malformations). Studies with women treated with carbamazepine for epilepsy have shown that on average 4-5 babies in every 100 will have serious physical birth abnormalities. This is compared with 2 to 3 babies in every 100 born to women who do not have epilepsy.
These abnormalities can develop early in pregnancy, even before you know you are pregnant. The most common types of major congenital malformations reported for carbamazepine include spina bifida (where the bones of the spine are not properly developed); facial and skull malformations including cleft lip/palate; skeletal, heart, urinary tract and sexual organ malformations.
Studies have found that the risk of physical birth abnormalities increases with increasing doses of carbamazepine. Therefore, it is important that where possible you are prescribed the lowest dose to control your epilepsy.
Ask your doctor about taking folic acid when trying for a baby and during pregnancy. Folic acid may lower the general risk of serious physical birth abnormalities that exists with all pregnancies.
Taking more than one epilepsy medicine at the same time may also increase the risk of physical birth abnormalities. This means that where possible, your doctor should consider using one epilepsy medicine to control your epilepsy.
Studies suggest that taking carbamazepine during pregnancy does not increase the risk the child may have difficulties with learning and thinking ability.
If you take carbamazepine during pregnancy, your baby is also at risk for bleeding problems right after birth. Your doctor may give you and your baby a medicine to prevent this.
Breastfeeding
Mothers taking Carbamazepine SUN can breastfeed their babies, but you must tell the doctor as soon as possible if you think that the baby is suffering side effects such as excessive sleepiness, skin reaction or yellow skin and eyes, dark urine or pale stools.
Fertility
You should use an effective method of contraception throughout your treatment with Carbamazepine SUN and for a period of 28 days, after discontinuation of treatment. Irregularity of the menstrual period may occur in women taking hormonal contraceptives (birth control medicines) and Carbamazepine SUN. The hormonal contraceptive may become less effective and you should consider using a different or additional non-hormonal contraceptive method. Ask your doctor about effective contraception.
Will there be any problems with driving or using machinery? Carbamazepine SUN can make you feel dizzy or drowsy, or may cause blurred vision, double vision, or you may have a lack of muscular coordination, especially at the start of treatment or when the dose is changed. If you are affected in this way, or if your eyesight is affected, you should not drive or operate machinery.
The doctor will tell you how much Carbamazepine SUN to take and when to take it. Always follow his/her instructions carefully. The dose will be on the pharmacist’s label. Check the label carefully. It is important to take the Carbamazepine SUN at the right times. If you are not sure, ask your
doctor or pharmacist. Keep taking your medicine for as long as you have been told, unless you have any problems. In that case, check with your doctor.
Your doctor will usually start Carbamazepine SUN at a fairly low dose which can then be increased to suit you individually. The dose needed varies between patients. You can take Carbamazepine SUN during, after or between meals. Shake the bottle before you measure out your dose. You are usually told to take a dose two or three times a day.
To treat epilepsy the usual doses are: Adults: 800-1,200 mg a day, although higher doses may be necessary. If you are elderly you might require a lower dose.
Children aged up to and over 1 year: Usually 10-20 mg/kg body weight daily in several divided doses. Your doctor will tell you how much liquid the child should take.
To treat trigeminal neuralgia the usual dose is 600-800 mg a day. The maximum dose is 1200 mg a day. If you are elderly you might require a lower dose. Once the pain is controlled, your doctor will probably reduce the dose.
To treat mood swings the usual dose is 400-600 mg a day.
If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, though, just take the next dose and forget about the one you missed .
If you accidentally take too much Carbamazepine SUN, tell your doctor or your nearest hospital casualty department. Take your medicine pack with you so that people can see what you have taken.
Carbamazepine SUN does not usually cause problems, but like all medicines, it can sometimes cause side effects.
Stop taking Carbamazepine SUN and tell your doctor straight away if you notice:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from the available data):
Do not be alarmed by this list. Most people take Carbamazepine SUN without any problems.
If any of the symptoms become troublesome, or if you notice anything else not mentioned here, please go and see your doctor. He/she may want to give you a different medicine.
There have been reports of bone disorders including osteopenia and osteoporosis (thinning of the bone) and fractures. Check with your doctor or pharmacist if you are on long-term antiepileptic medication, have a history of osteoporosis, or take steroids.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store below 25°C. Keep the bottle tightly closed between doses.
Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of that month.
Use this medicine within 30 days after first opening the bottle.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Bottles with a child resistant plastic cap.
Pack sizes: 300 ml and 500 ml.
Not all pack sizes may be marketed.
This leaflet was last revised in 12/2023
PL 31750/0096
V015
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
+44 (0) 208 848 5052